|
CardioGenomicSM Profile Identifies genetic single nucleotide polymorphisms associated with increased risk of developing atherosclerosis, hypertension, and coronary artery disease. Risk factors include methylation defects, iron overload, hyper-coagulation syndromes, cholesterol regulation defects, inflammation, general risk markers and cardio-protective markers. OsteoGenomicSM Profile Identifies genetic single nucleotide polymorphisms associated with increased risk of developing osteopenia and osteoporosis. Risk factors include collagen synthesis, calcium metabolism, vitamin D3 activity, parathyroid hormone action, osteoclastic activity, and chronic inflammation. DetoxiGenomicSM Profile Identifies genetic single nucleotide polymorphisms associated with increased risk of developing detoxification defects especially with increased exposure to xenobiotics and other toxins. Risk factors include altered cytochrome P-450 activity in phase 1 detoxification, impaired glutathione conjugation and acetylation in phase 2 reactions, altered catecholamine methylation and increased oxidative stress. Detoxification defects have been associated with increased risk for certain cancers, chronic fatigue, multiple chemical sensitivity, and alcoholism. ImmunoGenomicSM Profile Identifies genetic single nucleotide polymorphisms associated with increased risk of developing defects in immune competence and surveillance. Risk factors include altered interleukin production and activity within the body and increased production of other cytokines like tissue necrosis factor alpha that may lead to conditions characterized by chronically up-regulated inflammatory response. Immunologic polymorphisms have been associated with increased risk of asthma, atopy, osteopenia, heart disease, and infectious diseases. |
Predictive
Genomic Profiles